Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

3-(1-methyl-4-(1-methyl4-(1-methyl-4-(8-(2'-carboxamidoethyloxy)-7-methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one)pyrrole-2-carboxamido)pyrrole-2-carboxamido)pyrrole-2-carboxamido)propionamidine MeSH Supplementary Concept Data 2025


MeSH Supplementary
3-(1-methyl-4-(1-methyl4-(1-methyl-4-(8-(2'-carboxamidoethyloxy)-7-methoxy-1,2,3,11a-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazepin-5-one)pyrrole-2-carboxamido)pyrrole-2-carboxamido)pyrrole-2-carboxamido)propionamidine
Unique ID
C421502
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C421502
Entry Term(s)
uglysy10 cpd
uglysyl10 cpd
Registry Numbers
0
Heading Mapped to
*Benzodiazepinones
*Distamycins
Frequency
1
Note
inhibits DNA binding to Sp1 transcription factor; structure in first source
Source
Nucleosides Nucleotides Nucleic Acids 2000 Aug;19(8):1219-29
Date of Entry
2001/03/12
Revision Date
2002/06/17
page delivered in 0.004s